The malaria pill hydroxycholoroquine failed to help coronavirus patients in 2 big studies
Business Insider -

AP Photo/David J. Phillip

Two studies published recently medical journals found that the anti-malaria medication hydroxychloroquine failed to help hospitalized coronavirus patients.

The studies, both observational, looked at the outcomes of more than 2,000 hospitalized coronavirus patients in New York collectively. 

Hydroxychloroquine got attention early on in the pandemic as a potential treatment for COVID-19, the disease caused by the novel coronavirus. It has not been approved by the FDA for...

Read this story at


Related Articles